Quercetin ameliorates thioacetamide-induced hepatic fibrosis and oxidative stress by antagonizing the Hedgehog signaling pathway
- PMID: 35696520
- DOI: 10.1002/jcb.30296
Quercetin ameliorates thioacetamide-induced hepatic fibrosis and oxidative stress by antagonizing the Hedgehog signaling pathway
Abstract
The Hedgehog (Hh) pathway has emerged as a potential target for effectual hepatic repair based on convincing clinical and preclinical evidence that proves its significance in regulating hepatic damage. The purpose of this study is to probe the effect of quercetin on liver fibrosis through the modulation of the Hh pathway. Healthy male Wistar rats were divided into four groups (n = 10). The control group was treated with saline, rats in the remaining three groups received twice a week intoxication with intraperitoneal injections of thioacetamide (200 mg/kg) for the induction of hepatic fibrosis for 6 weeks. After 28 days of quercetin and silymarin treatment, histological changes, serum biochemical index, antioxidant enzyme activity, key mediators of Hh pathway and inflammation were analyzed. Serological analysis showed statistically improved cholesterol, H.D.L-Cholesterol, and L.D.L-Cholesterol in the treatment groups. Superoxide dismutase and glutathione levels were found to be increased after the treatment with quercetin and silymarin. mRNA expression of important mediators of the Hh signaling, and inflammation including Shh, Ihh, Ptch-1, Smo, Hhip, Gli-3, TNF-α, NFκ-β, and Socs-3 were significantly downregulated after the use of quercetin and silymarin. Quercetin also minimized the thioacetamide-induced histopathological changes, as confirmed by a lower degree of hepatic lobule degeneration, the intralobular occurrence of inflammatory cells, and a lower degree of hepatocytic necrosis. Sudan Black B staining showed remarked lipids improvements in the treatment groups. Taken together, these findings demonstrate that quercetin could ameliorate hepatic fibrosis by antagonizing the hedgehog pathway and also suggest the hedgehog pathway as a potential therapeutic target for the treatment of liver fibrosis.
Keywords: Hedgehog pathway; hepatic fibrosis; oxidative stress; quercetin; silymarin.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.Eur J Pharmacol. 2011 Nov 30;670(2-3):593-600. doi: 10.1016/j.ejphar.2011.08.041. Epub 2011 Sep 8. Eur J Pharmacol. 2011. PMID: 21925495
-
Chlorogenic acid, quercetin, coenzyme Q10 and silymarin modulate Keap1-Nrf2/heme oxygenase-1 signaling in thioacetamide-induced acute liver toxicity.Life Sci. 2021 Jul 15;277:119460. doi: 10.1016/j.lfs.2021.119460. Epub 2021 Mar 31. Life Sci. 2021. PMID: 33811899
-
Dendropanax morbifera Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways.Int J Biol Sci. 2019 Feb 13;15(4):800-811. doi: 10.7150/ijbs.30356. eCollection 2019. Int J Biol Sci. 2019. PMID: 30906211 Free PMC article.
-
Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.Fundam Clin Pharmacol. 2011 Apr;25(2):248-57. doi: 10.1111/j.1472-8206.2010.00824.x. Fundam Clin Pharmacol. 2011. PMID: 20408881
-
Hedgehog Signaling: Implications in Liver Pathophysiology.Semin Liver Dis. 2023 Nov;43(4):418-428. doi: 10.1055/a-2187-3382. Epub 2023 Oct 6. Semin Liver Dis. 2023. PMID: 37802119 Review.
Cited by
-
Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress.World J Hepatol. 2023 Oct 27;15(10):1091-1108. doi: 10.4254/wjh.v15.i10.1091. World J Hepatol. 2023. PMID: 37970620 Free PMC article. Review.
-
Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways.Front Pharmacol. 2025 Jun 9;16:1586231. doi: 10.3389/fphar.2025.1586231. eCollection 2025. Front Pharmacol. 2025. PMID: 40552161 Free PMC article.
-
Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.Aging (Albany NY). 2024 Feb 15;16(4):3773-3789. doi: 10.18632/aging.205559. Epub 2024 Feb 15. Aging (Albany NY). 2024. PMID: 38364259 Free PMC article.
-
Quercetin Alleviates Pulmonary Fibrosis in Silicotic Mice by Inhibiting Macrophage Transition and TGF-β-Smad2/3 Pathway.Curr Issues Mol Biol. 2023 Apr 5;45(4):3087-3101. doi: 10.3390/cimb45040202. Curr Issues Mol Biol. 2023. PMID: 37185726 Free PMC article.
-
Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems.Int J Mol Sci. 2024 Aug 28;25(17):9346. doi: 10.3390/ijms25179346. Int J Mol Sci. 2024. PMID: 39273295 Free PMC article. Review.
References
REFERENCES
-
- Machado MV, Diehl AM. Hedgehog signalling in liver pathophysiology. J Hepatol. 2018;68:550-562.
-
- Chang Y, Li H. Hepatic antifibrotic pharmacotherapy: Are we approaching success? J Clin Transl Hepatol. 2020;8:222-229.
-
- Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 1980;287:795-801.
-
- Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut. 2001;49:565-576.
-
- Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: a comprehensive review. Bosn J Basic Med Sci. 2018;18:8-20.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous